Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | cdc48-like protein, putative | 0.0139 | 0.9193 | 0.5 |
Toxoplasma gondii | cell division protein CDC48CY | 0.0146 | 1 | 1 |
Toxoplasma gondii | cell division protein CDC48AP | 0.0087 | 0.3706 | 0.0000097958 |
Loa Loa (eye worm) | vesicle-fusing ATPase | 0.0086 | 0.3518 | 1 |
Plasmodium vivax | cell division cycle protein 48 homologue, putative | 0.0139 | 0.9193 | 1 |
Mycobacterium tuberculosis | Putative conserved ATPase | 0.0087 | 0.3706 | 0.5 |
Trypanosoma brucei | Valosin-containing protein | 0.0139 | 0.9193 | 0.5 |
Onchocerca volvulus | Transitional endoplasmic reticulum ATPase homolog | 0.0146 | 1 | 0.5 |
Brugia malayi | valosin containing protein | 0.0086 | 0.3518 | 1 |
Trichomonas vaginalis | spermatogenesis associated factor, putative | 0.0146 | 1 | 0.5 |
Plasmodium falciparum | cell division cycle protein 48 homologue, putative | 0.0139 | 0.9193 | 0.5 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.0146 | 1 | 1 |
Brugia malayi | vesicle-fusing ATPase | 0.0086 | 0.3518 | 1 |
Echinococcus multilocularis | transitional endoplasmic reticulum atpase | 0.0146 | 1 | 1 |
Entamoeba histolytica | transitional endoplasmic reticulum ATPase, putative | 0.0139 | 0.9193 | 0.5 |
Mycobacterium ulcerans | ATPase | 0.0087 | 0.3706 | 0.5 |
Trypanosoma cruzi | Valosin-containing protein, putative | 0.0139 | 0.9193 | 0.5 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.0139 | 0.9193 | 0.9122 |
Leishmania major | Transitional endoplasmic reticulum ATPase, putative,valosin-containing protein homolog | 0.0139 | 0.9193 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0086 | 0.3518 | 1 |
Giardia lamblia | AAA family ATPase | 0.0087 | 0.3706 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.